- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT03901222
3D Analysis of the Effects of tDCS (Transcranial Direct Current Stimulation) on a Functional Task in High Level Athletes
3D Analysis of the Effects of tDCS on a Functional Task in High Level Athletes
Study Overview
Detailed Description
Recruitment :
Relatively high level athletes will be recruited through social media and advertisements.
Each subject came twice to the Liege University Hospitals' Human Movement Analysis Laboratory.
After placing the different infrared emitters and placing and calibrating the surface EMG electrodes, subjects underwent 3 maximal squat jumps (without upper limb implication). They were then familiarized with the fatigue protocol (8 jumps at a 33 jumps per minute pace).
Then each subject received either bi-anodal tDCS of sham tDCS. Neither the evaluator or the subject knew which they were receiving. Immediately following tDCS, subjects underwent another warmup 3 maximal squat jumps, and then the fatigue protocol (comprised of 30 maximal jumps at a rate of 33 per minute).
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
-
Liege, Belgium, 4000
- Liege Univeristy Hospital
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- At least 10 hours of sport a week
- Right handed and footed
Exclusion Criteria:
- One on the TSST (in high and relatively high risk sections)
- Previous neurological or orthopedic pathologies affecting limbs
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Health Services Research
- Allocation: Randomized
- Interventional Model: Crossover Assignment
- Masking: Triple
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Sham Comparator: Sham tDCS
Subjects will receive 20 minutes of Sham anodal tDCS
|
20 minutes of anodal tDCS (C3 & C4/FPZ) 2mA or sham
Other Names:
|
|
Active Comparator: Bi-Anodal tDCS
Subjects will receive 20 min of bi-anodal tDCS
|
20 minutes of anodal tDCS (C3 & C4/FPZ) 2mA or sham
Other Names:
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Peak Height
Time Frame: Changes between Prior and Immediately Following tDCS and Sham
|
Peak height (measured by the 3D device) is measured after each of the 30 repetitions as well as after the 3 jumps before and after tDCS.
Height decrease will also be looked at
|
Changes between Prior and Immediately Following tDCS and Sham
|
|
Gluteal EMG (Electromyography) recordings (% of maximal EMG value)
Time Frame: Changes between Prior and Immediately Following tDCS and Sham
|
Bilateral Gluteal EMG
|
Changes between Prior and Immediately Following tDCS and Sham
|
|
Quadriceps EMG (Electromyography) recordings (% of maximal EMG value)
Time Frame: Changes between Prior and Immediately Following tDCS and Sham
|
Bilateral Quadriceps EMG triceps surae will be measured
|
Changes between Prior and Immediately Following tDCS and Sham
|
|
Triceps EMG (Electromyography) recordings (% of maximal EMG value)
Time Frame: Changes between Prior and Immediately Following tDCS and Sham
|
Bilateral Triceps Surae EMG
|
Changes between Prior and Immediately Following tDCS and Sham
|
Collaborators and Investigators
Sponsor
Investigators
- Principal Investigator: Stephen Bornheim, Msc, Liege University Hospital
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.